<DOC>
	<DOCNO>NCT02651636</DOCNO>
	<brief_summary>The aim study investigate effect combine treatment alpha-lipoic acid myoinositol clinical , endocrine metabolic feature woman affect PCOS . The study Group include 40 patient treat combined therapy alpha-lipoic acid ( 800 mg ) , myoinositol ( 2000 mg ) folic acid ( 400 mcg ) daily six month . The investigation include menstrual pattern , hirsutism score , hormonal assay , oral glucose tolerance test , lipidic profile baseline six month treatment .</brief_summary>
	<brief_title>Combined Therapy With Myo-inositol Alpha-Lipoic Acid PCOS Women</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>woman PCOS accordance Rotterdam criterion pregnancy past history cardiovascular disease , diabetes mellitus ( impaired glucose tolerance determine standard 75 g oral glucose tolerance test ) , hypertension , significant liver renal impairment , hormonal dysfunction ( hypothalamic , pituitary , thyroidal adrenal cause clinical sign ) , neoplasms , unstable mental illness .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>